24 May 2013
Keywords: medarex, 1st-qtr, sales, soar, loss, grows, new
Article | 30 May 2005
New Jersey, USA-headquartered biopharmaceutical group Medarex, which focuses on the development of antibody-based therapeutics, has reported
a steep increase in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 May 2005
23 May 2013
© 2013 thepharmaletter.com